Botulax 200 Unit

Botulax is made in Korea by Hugel Pharma.

Clostridium Botulinum Toxin A type

(strain: Clostridium Botulinum CBFC26)

(separate specification) 200Units(U)



It appears as a lyophilized white powder for injection in a colorless transparent vial.

Expire date will be 36 months from the manufacture date.

The unopened lyophilized vial should be stored in a freezer (below -5 degree) or refrigerator (2-8 degree)

Botulax is made in Korea by Hugel Pharma. The advantages of Botulax is that Botulax is strictly controlled for safety and high stable potency, has purity of 99% and safety & efficacy have been successfully proved compared with Botox.

It appears as a lyophilized white powder for injection in a colorless transparent vial.

Expire date will be 36 months from the manufacture date.


Characteristics of Botulax:

Higher specific activity than those of other company’s botolinum toxin products by improving lyophilization process

Botulinum toxin type A neutroxin: purified from Clostridium botulinum type A

Albumin: Human serum albumin, bulking and stabilizing agent and adhesion reducer.

  • Features of Botulax Botulium Toxin Type A
  • Excellent Effect – Result appeciable improvement
  • Simple Procedure – Just by few tiny injections
  • Short Treatment – 10 minutes, as short as a tea break
  • No Down Time – Resume normal work right away
  • Fast Onset- Take only 2 to 3 days to see noticeable effect
  • Outstanding Efficacy – Over 98% users satisfied with the Botulax® treatments
  • Proven efficacy & Safety – The efficacy and safety of Botulium Toxin Type A are proved and verified to be comparable to botox in clinical studies.
  • Global Product – Global Product, Botulium Toxin Type A has been sold in over 25 countries.
  • Guarateed Safety – Approved by Health Authorities with over 10 years ’clinical practices.

Applications / Indications

Not just cosmetic Botox, Botulium Toxin Type A also has therapeutic applications, Botulium Toxin Type A is used for the treatment of benign essential blepharspasm in patients 18 years of age and above. For the treatment of equinus foot deformity due to spasticity in pediatric cerebral palsy patients 2 years of age and above. And as many know Botox, for temporary improvement of serious glabellar wrinkles ranging from moderate to severe associated with corrugators muscle and / or procerus muscle activities in adults over the age of 18 and below the age of 65. The vials are generally stored in a freezer or refrigerator and they retain a shelf life of 24 months.


For blepharospasm the initial recommended dose is 1.25 – 2.5 U (0.05 mL to 0.1 mL volume at each site) injected into the medial and lateral pre-tarsal orbicularis oculi of the upper lid and into the lateral pre-tarsal orbicularis oculi of the lower lid … For pediatric cerebral palsy, a total dose of 4U / kg bodyweight is recommended for the affected gastrocnemius muscle in patients with hemiplegia. And in patients with diplegia, the recommended dose is 6U / kg bodyweight divided between both legs. The maximum dose administered must not exceed 200U / patient at a time. For Glabellar wrinkles reconstituted sterile saline.


In Blepharospasm, the effects should appear within three days and peak after three weeks. For pediatric cerebral palsy applications, the expectation is improvement within four weeks of the injection. The effects vary for glabellar wrinkles due to the usually individualized dosages.


There are no reviews yet.

Be the first to review “Botulax 200 Unit”

Your email address will not be published.